Characteristics of lung cancers harboring NRAS mutations.

Ohashi K, Sequist LV, Arcila ME, Lovly CM, Chen X, Rudin CM, Moran T, Camidge DR, Vnencak-Jones CL, Berry L, Pan Y, Sasaki H, Engelman JA, Garon EB, Dubinett SM, Franklin WA, Riely GJ, Sos ML, Kris MG, Dias-Santagata D, Ladanyi M, Bunn PA, Pao W
Clin Cancer Res. 2013 19 (9): 2584-91

PMID: 23515407 · PMCID: PMC3643999 · DOI:10.1158/1078-0432.CCR-12-3173

MeSH Terms (25)

Adenocarcinoma Adult Aged Aged, 80 and over Antineoplastic Agents Benzimidazoles Cell Line, Tumor DNA Mutational Analysis Female Gene Frequency Genetic Association Studies GTP Phosphohydrolases Humans Inhibitory Concentration 50 Lung Neoplasms Male Membrane Proteins Middle Aged Mutation, Missense Protein Kinase Inhibitors Proto-Oncogene Proteins Proto-Oncogene Proteins p21(ras) Pyridones Pyrimidinones ras Proteins

Connections (4)

This publication is referenced by other Labnodes entities: